Cargando…
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment
Lung cancer is a leading cause of cancer-related deaths worldwide. About 10–30% of patients with non-small cell lung cancer (NSCLC) harbor mutations of the EGFR gene. The Tumor Microenvironment (TME) of patients with NSCLC harboring EGFR mutations displays peculiar characteristics and may modulate t...
Autores principales: | Madeddu, Clelia, Donisi, Clelia, Liscia, Nicole, Lai, Eleonora, Scartozzi, Mario, Macciò, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224267/ https://www.ncbi.nlm.nih.gov/pubmed/35742933 http://dx.doi.org/10.3390/ijms23126489 |
Ejemplares similares
-
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer
por: Madeddu, Clelia, et al.
Publicado: (2023) -
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review
por: Massa, Elena, et al.
Publicado: (2021) -
Cancer cachexia and chronic inflammation: an unbreakable bond
por: Macciò, Antonio, et al.
Publicado: (2023) -
Molecular Basis and Advances in Targeted Immunotherapy for Cancer
por: Macciò, Antonio, et al.
Publicado: (2023) -
Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer
por: Madeddu, Clelia, et al.
Publicado: (2019)